Abstract
Twenty antiepileptic drugs (AEDs) are available in the USA and many areas of the world for chronic therapy to prevent or minimize seizures. For some seizure types, efficacy differences are modest, but all the drugs are distinctive in one or more ways and possess unique mechanisms of action, side effects, or pharmacokinetics. An understanding of these properties is needed to make an optimal selection of monotherapy and combined AED therapy.